NASDAQ:JAZZ

BeOne Dips on Wall Street After Cancer Results, Market Looks On
·······

BeOne Dips on Wall Street After Cancer Results, Market Looks On

BeOne Medicines shares fell 2.7% to $291.98 Thursday afternoon despite positive late-stage cancer trial data, while the Nasdaq Biotechnology Index rose 1.1%. The Phase 3 HERIZON-GEA-01 trial showed BeOne’s ZIIHERA combo reached median overall survival of 26.4 months versus 19.2 months for the control. Investors appeared cautious ahead of more data expected at the ASCO meeting next week.
May 28, 2026

Stock Market Today

  • Investing $5,000 Yearly in ASX Shares: Can It Build Wealth?
    May 28, 2026, 4:53 PM EDT. Investing $5,000 annually into ASX shares with an average 9% return, while not guaranteed, can grow significantly due to compounding - where earnings generate their own earnings. After 20 years, such investments could reach around $280,000, and after 30 years, approximately $740,000. At 34 years, the portfolio might surpass $1 million without increasing the annual contribution. Experts recommend a diversified approach, such as using ASX ETFs like Vanguard's MSCI Index International Shares ETF (ASX: VGS), combined with select quality stocks. The key is discipline, patience, and allowing time to harness compounding effects across market cycles.